1:15 pm – 2:00 pm EDT Explore the Clinical Implications of Uncontrolled Type 2 Inflammation in Asthma and COPD
1:30 pm – 1:50 pm EDT ILLUMISITE™ fluoroscopic navigation platform as technology to aid in therapy delivery
1:30 pm – 2:00 pm EDT The Role of Inflammation in Patients with Community-Acquired Pneumonia: Clinical Trial Update on REPAVID-22
6:30 pm – 9:30 pm EDT A Discussion Amongst Experts: Addressing the Complexities of Titrating PAH Therapy
6:30 pm – 9:30 pm EDT PH-ILD Reimagined: 2023 Updates in Disease State, Treatment, and Device Options
11:30 am – 11:50 am EDT Detecting a genomic UIP pattern to improve ILD diagnostic and prognostic confidence with the Envisia Genomic Classifier
11:30 am – 12:00 pm EDT A Targeted Biologic for Eosinophil-Driven Disease in the Unified Airway: Reviewing the Latest Data in Severe Eosinophilic Asthma (SEA) and Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
11:30 am – 12:15 pm EDT Featured Featured Closing the Gaps: The Importance of Early Detection, Equity, and Optimization of Care in Lung Cancer
12:00 pm – 12:20 pm EDT Clinical Case Review: Uncontrolled Asthma Patient on Medium-Dose Inhaled Corticosteroids
12:30 pm – 12:50 pm EDT Obesity Hypoventilation Syndrome: From Pathophysiology to Clinical Management
1:15 pm – 2:00 pm EDT Confirming the Diagnosis of PAH: What Is the Role of Right Heart Catheterization?
1:30 pm – 1:50 pm EDT Featured Featured Hidden in plain sight: understanding inflammation in bronchiectasis
1:30 pm – 2:00 pm EDT Hybrid Bronchoscopy Solution: Single-Use and Reusable Bronchoscopes – The Right Scope, for the Right Patient, in the Right Situation
6:30 pm – 8:30 pm EDT Featured Featured Answering the Call in Severe Asthma: Expanding Roles for Biologic Treatment Regimens
6:30 pm – 9:30 pm EDT Current Gaps in Therapy in Patients with Nontuberculous Mycobacterial Lung Disease (NTM-LD): Improving Adherence With Guideline-Recommended Strategies
11:30 am – 11:50 am EDT Trends in Cystic Fibrosis (CF) Epidemiology: Why It Matters for Adult Pulmonologists
11:30 am – 11:50 am EDT Hyperinflammation in Patients With Acute Respiratory Distress Syndrome: Clinical Trial Update on RESPIRATIO
11:30 am – 12:00 pm EDT Expert Perspectives: Identification and Management of Eosinophilic Granulomatosis With Polyangiitis
11:30 am – 12:15 pm EDT Host inflammatory response in viral lower respiratory tract infections – friend or foe?
12:30 pm – 12:50 pm EDT Understanding Bronchiolitis Obliterans Syndrome (BOS): What Does it Mean for Patients and Caregivers?
12:30 pm – 1:00 pm EDT Does the Current Approach to Asthma Rescue Therapy Meet the Challenge of Exacerbations?
1:15 pm – 2:00 pm EDT Pulmonary Arterial Hypertension (PAH): Overview, Pathophysiology, and Clinical Considerations
6:30 pm – 8:30 pm EDT Featured Featured Disrupting the Vicious Vortex in NCFBE: The Evolving Role of Emerging Neutrophil Agents
6:30 pm – 9:00 pm EDT Featured Featured Raising the Standard in Pulmonary Arterial Hypertension: Contemporary Approaches to Risk-Guided Treatment